Evidence map›Paper›PMID 18301782›Full record

ReviewNuclear receptor signaling2008

Nuclear receptor coactivator/coregulator NCoA6(NRC) is a pleiotropic coregulator involved in transcription, cell survival, growth and development.

Muktar A Mahajan, Herbert H Samuels

Open access · hybridAbstract readReview
In one paragraph

Review in Nuclear receptor signaling, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Do LRG1-SERPINA1 Interactions Modulate Fibrotic and Inflammatory Signatures in Rheumatoid Arthritis? A Proteomic and In Silico Investigation.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Acta biochimica et biophysica Sinica · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Muktar A MahajanDepartment of Pharmacology, NYU School of Medicine, New York, New York, USA. muktar.mahajan@med.nyu.edu
Herbert H Samuels
New York University · US

Funding

METABOLIC EFFECTS OF THYROID HORMONE IN CELL CULTURER01DK016636 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SAMUELS, HERBERT H · 1986 to 2007
$6.0M
Metabolic Effects of Thyroid HormoneR56DK016636 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SAMUELS, HERBERT H · 2009 to 2009
$211k
METABOLIC EFFECTS OF THYROID HORMONER37DK016636 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SAMUELS, HERBERT H · 1991 to 1998
–
NIDDK NIH HHS DK16636NIDDK NIH HHS R01 DK016636NIDDK NIH HHS R56 DK016636
6 · The paper itself

Abstract

NCoA6 (also referred to as NRC, ASC-2, TRBP, PRIP and RAP250) was originally isolated as a ligand-dependent nuclear receptor interacting protein. However, NCoA6 is a multifunctional coregulator or coactivator necessary for transcriptional activation of a wide spectrum of target genes. The NCoA6 gene is amplified and overexpressed in breast, colon and lung cancers. NCoA6 is a 250 kDa protein which harbors a potent N-terminal activation domain, AD1; and a second, centrally-located activation domain, AD2, which is necessary for nuclear receptor signaling. The intrinsic activation potential of NCoA6 is regulated by its C-terminal STL regulatory domain. Near AD2 is an LxxLL-1 motif which interacts with a wide spectrum of ligand-bound NRs with high-affinity. A second LxxLL motif (LxxLL-2) located towards the C-terminal region is more restricted in its NR specificity. The potential role of NCoA6 as a co-integrator is suggested by its ability to enhance transcriptional activation of a wide variety of transcription factors and from its in vivo association with a number of known cofactors including CBP/p300. NCoA6 has been shown to associate with at least three distinct coactivator complexes containing Set methyltransferases as core polypeptides. The composition of these complexes suggests that NCoA6 may play a fundamental role in transcriptional activation by modulating chromatin structure through histone methylation. Knockout studies in mice suggest that NCoA6 is an essential coactivator. NCoA6-/- embryos die between 8.5-12.5 dpc from general growth retardation coupled with developmental defects in the heart, liver, brain and placenta. NCoA6-/- MEFs grow at a reduced rate compared to WT MEFs and spontaneously undergo apoptosis, indicating the importance of NCoA6 as a prosurvival and anti-apoptotic gene. Studies with NCoA6+/- and conditional knockout mice suggest that NCoA6 is a pleiotropic coregulator involved in growth, development, wound healing and maintenance of energy homeostasis.

Indexed as

AnimalsCell SurvivalEnergy MetabolismGenes, RegulatorGrowth and DevelopmentHomeostasisHumansIntracellular Signaling Peptides and ProteinsMethyltransferasesNuclear Receptor Coactivatorsp300-CBP Transcription FactorsReceptors, Cytoplasmic and NuclearTranscription FactorsWound HealingIntracellular Signaling Peptides and ProteinsMethyltransferasesNCOA6 protein, humanNuclear Receptor Coactivatorsp300-CBP Transcription FactorsReceptors, Cytoplasmic and NuclearTranscription Factors

Identifiers

PMID18301782
PMCPMC2254332
OpenAlexW2035498177

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.